New Long-Read Genetic Test Enables Faster and More Comprehensive Diagnosis of Rare Diseases
November 18, 2025
Brand Name :
Quixin, Iquix
Synonyms :
levofloxacin ophthalmic
Class :
Quinolones, Ophthalmic
Brand Name :
Quixin, Iquix
Synonyms :
levofloxacin ophthalmic
Class :
Quinolones, Ophthalmic
Dosage Forms & StrengthsÂ
Ophthalmic solutionÂ
0.5%Â
Put 1 to 2 drops into the affected eye every two hours on day 1 and day 2 and while awake, use up to 8 times daily
Put 1 to 2 drops every four hours and not more than four times daily on day 3 to day 7
Dosage Forms & StrengthsÂ
Ophthalmic solutionÂ
0.5%Â
1.5%Â
<1 year: Safety and efficacy not determined
1 year or older:
Put 1 to 2 drops in affected eye every two hours on day 1 and day 2 and while awake use up to 8 times daily
Put 1 to 2 drops every four hours and not more than four times daily on day 3 to day 7
Refer to adult dosingÂ
Actions and SpectrumÂ
levofloxacin ophthalmic inhibits bacterial DNA gyrase and topoisomerase, enzymes that are essential for bacterial DNA replication, repair, and transcription. Â
By interfering with these processes, levofloxacin prevents the bacteria from multiplying and ultimately leads to their death. levofloxacin ophthalmic has a spectrum of activity against various bacteria, making it effective against a wide range of eye infections.
Frequency not defined Â
Transient decrease in visionÂ
HeadacheÂ
Allergic reactionsÂ
Lid edemaÂ
PhotophobiaÂ
Ocular drynessÂ
Ocular itchingÂ
Foreign body sensation Â
FeverÂ
PharyngitisÂ
Transient ocular burningÂ
Ocular pain or discomfortÂ
Black Box WarningÂ
None Â
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: CÂ
Lactation: It may be distributed into human milkÂ
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
levofloxacin ophthalmic belongs to the fluoroquinolone class of antibiotics. These enzymes are involved in DNA replication, repair, and transcription in bacteria. By interfering with their function, levofloxacin prevents the bacteria from replicating and dividing leading to their death.Â
PharmacodynamicsÂ
levofloxacin ophthalmic demonstrates concentration-dependent bactericidal activity. The higher the concentration of levofloxacin at the site of infection, the more effective it is in killing bacteria. Â
PharmacokineticsÂ
Absorption  Â
levofloxacin ophthalmic is absorbed through the cornea, it is the transparent front part of the eye.Â
DistributionÂ
levofloxacin ophthalmic distributes into the anterior chamber of the eye and various ocular tissues.Â
MetabolismÂ
levofloxacin is not significantly metabolized in the body after ophthalmic application.Â
Elimination and excretionÂ
levofloxacin ophthalmic and its metabolites are excreted through the kidneys.
AdministrationÂ
levofloxacin ophthalmic solution is applied directly to the eye, in the form of eye drops.
Patient information leafletÂ
Generic Name: levofloxacin ophthalmicÂ
Why do we use levofloxacin ophthalmic?Â
levofloxacin eye drops are commonly used for the treatment of bacterial conjunctivitis. Â
levofloxacin ophthalmic helps to eliminate the bacteria causing the infection, reducing redness, irritation, and discharge associated with conjunctivitis.Â